Condition
Stage IVA Pancreatic Cancer
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownPharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNCT04067960 · 2019-06-06
COMPLETEDPalbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsNCT02897375 · 2016-10-24
COMPLETEDTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsNCT02650635 · 2016-02-05
TERMINATEDVaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerNCT00019006 · 1995-03-01
COMPLETEDCommon interventions
Biospecimen CollectionPROCEDURE1CarboplatinDRUG1CisplatinDRUG1CyclophosphamideDRUG1Detox-B adjuvantDRUG1Genetic TestingOTHER1Laboratory Biomarker AnalysisOTHER1PalbociclibDRUG1PegfilgrastimBIOLOGICAL1Pharmacological StudyOTHER1Quality-of-Life AssessmentOTHER1Questionnaire AdministrationOTHER1ras peptide cancer vaccineDRUG1TLR8 Agonist VTX-2337DRUG1
Leading sponsors
Trial status mix
COMPLETED3
TERMINATED1
Phase mix
PHASE13
EARLY_PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.